The Cigna Group (CI)
| Market Cap | 88.75B |
| Revenue (ttm) | 216.01B |
| Net Income (ttm) | 3.71B |
| Shares Out | 279.55M |
| EPS (ttm) | 12.73 |
| PE Ratio | 24.95 |
| Forward PE | 10.58 |
| Dividend | $5.60 (1.76%) |
| Ex-Dividend Date | Sep 4, 2024 |
| Volume | 2,258,898 |
| Open | 320.18 |
| Previous Close | 320.23 |
| Day's Range | 315.10 - 322.29 |
| 52-Week Range | 253.95 - 370.83 |
| Beta | 0.51 |
| Analysts | Strong Buy |
| Price Target | 392.24 (+23.56%) |
| Earnings Date | Oct 31, 2024 |
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other product... [Read more]
Financial Performance
In 2023, The Cigna Group's revenue was $195.19 billion, an increase of 8.42% compared to the previous year's $180.03 billion. Earnings were $5.16 billion, a decrease of -22.97%.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for CI stock is "Strong Buy." The 12-month stock price forecast is $392.24, which is an increase of 23.56% from the latest price.
News
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
Cigna, Humana Merger Discussions Reportedly Revived
Humana (HUM) shares edged higher Monday morning on a report that The Cigna Group (CI) has resumed discussions to buy its smaller health insurance rival after negotiations fell apart last year. Cigna s...
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
In a significant development in the health insurance industry, Cigna Group CI has reinitiated discussions to merge with Humana Inc. HUM, potentially creating a giant in the sector.
Cigna, Humana Resume Merger Talks, Report Says. Why It's Different This Time.
Key developments since the talks between the healthcare insurers broke down last year mean a deal now looks more likely.
Potential Cigna buyout of Humana is a ‘when,' not an ‘if,' analyst says
Humana's stock looked to rally Monday. And Mizuho analyst Ann Hynes said she believes a buyout by Cigna Group is likely — it's just a matter of timing.
Cigna Healthcare Commits $600,000 To Reduce Food Insecurity Among Seniors
54 community-based organizations receive funds to support the dietary needs of older adults BLOOMFIELD, Conn. , Oct. 21, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cign...
Cigna resumes merger discussions with Humana, Bloomberg News reports
U.S. health insurer Cigna Group has revived efforts to merge with smaller rival Humana after abandoning the pursuit late last year, Bloomberg News reported on Friday, citing people familiar with the m...
Cigna Breaks Below 200-Day Moving Average
In trading on Friday, shares of The Cigna Group crossed below their 200 day moving average of $340.21, changing hands as low as $338.60 per share. The Cigna Group shares are currently trading off abou...
Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
Cigna said that Khan, along with Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, have made repeated and incorrect prejudgments that show bias against pharmacy-benefit managers.
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand.
3 Dividend Growth Stocks Set to Supercharge Your Portfolio
For dividend-paying companies, maintaining dividend growth is an essential way to demonstrate to investors that a firm is stable and enjoys long-term profitability. Dividend growth is also attractive ...
The Cigna Group's Third Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn. , Oct. 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host a c...
Dividend Stocks With Strong Q4 Seasonality
Entering October is the strongest period of the year for three-month returns, and shorter-term returns are also some of the best. Here we take a look at 30 dividend stocks in the S&P 500 that have bee...
CVS, Cigna unveil Medicare Advantage plans for 2025
CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people aged 65 and above, saying some members would pay $0 premium monthly for pres...
Cigna Healthcare Offers Medicare Customers Value, Stability and Choice with 2025 Plans
Plans available for every lifestyle and budget, including Medicare Advantage (MA) plans, Medicare Supplement plans, and standalone Prescription Drug Plans, all with competitive premiums and benefits. ...
The Cigna Group Issues 2024 Vitality In America Report, Revealing Increased Optimism Among Young Americans and Offering Insights on Workforce Health and Engagement
Third annual Vitality In America study shows more people achieving high vitality, driven by improved sense of energy. While Gen Z adults continue to have the lowest overall vitality, they are feeling...
Cigna: This Dividend Grower Could Be Worth Buying Now
The managed care company's total revenue and non-GAAP EPS climbed higher in the second quarter. Cigna's dividend is comfortably covered by non-GAAP EPS and free cash flow. Shares of the stock appear t...
Our Top 10 Dividend Growth Stocks - September 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and...
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
With the Federal Trade Commission (FTC) taking a scalpel to the pharmacy benefit managers (PBMs) of UnitedHealth Group Inc UNH, CVS Health Corp CVS and Cigna Group CI, investors are left wondering whi...
Pharmacy benefit managers respond to FTC's lawsuit over insulin drug prices
CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly inflating insulin prices.
Express Scripts Comments on FTC's Reckless Insulin Action
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS , Sept.
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group's Optum unit, CVS Caremark and Cigna's Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice'
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
FTC Sues CVS, Cigna, UnitedHealth Over Insulin Costs
The US Federal Trade Commission is accusing units of CVS, Cigna, and UnitedHealth of engaging in illegal rebate programs that drove up the price of insulin. Federal Trade Commission Office of Public A...
Explainer: Why are US pharmacy benefit managers under fire?
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to...